Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance abamectin
Proposed act with possible EEA relevance
Act under scrutiny by EEA EFTA
Draft Joint Committee Decision (JCD) under consideration
Entry into force of Joint Committee Decision (JCD) pending
Incorporated into the EEA Agreement and in force
Incorporated into the EEA Agreement but no longer in force
Legal status
EU legal act incorporated into the EEA Agreement by a Joint Committee Decision (JCD)
Area (EEA Agreement)
II Technical Regulations, Standards, Testing and Certification
II.XV Dangerous Substances
Joint committee decision (JCD)
174/2017
In force in the EEA
Yes
Legal Documents
Commission Implementing Regulation (EU) 2017/438 of 13 March 2017 amending Implementing Regulation (EU) No 540/2011 as regards the conditions of approval of the active substance abamectin
Framkvæmdarreglugerð framkvæmdastjórnarinnar (ESB) 2017/438 frá 13. mars 2017 um breytingu á framkvæmdarreglugerð (ESB) nr. 540/2011 að því er varðar skilyrði fyrir samþykki fyrir virka efninu abamektíni
Durchführungsverordnung (EU) 2017/438 der Kommission vom 13. März 2017 zur Änderung der Durchführungsverordnung (EU) Nr. 540/2011 hinsichtlich der Bedingungen für die Genehmigung des Wirkstoffs Abamectin
Kommisjonens gjennomføringsforordning (EU) 2017/438 av 13. mars 2017 om endring av gjennomføringsforordning (EU) nr. 540/2011 med hensyn til vilkårene for godkjenning av det aktive stoffet abamektin
History
Disclaimer: EEA-Lex is provided for information purposes only. The information is not guaranteed or promised to be current or complete and is not intended to replace any applicable legal sources.